Scott Kollins, PhD
Dr. Kollins is a tenured Professor and Vice-Chair for Research Strategy and Development in the Department of Psychiatry and Behavioral Sciences at the Duke University School of Medicine. Dr. Kollins is the Global Lead for ADHD and Substance Use Disorders at the Duke Clinical Research Institute (DCRI). He is also the Director of the Duke ADHD Program. He received his undergraduate degree in psychology from Duke University in 1992 and earned his Master’s and Doctorate degrees in Clinical Psychology from Auburn University in 1995 and 1997, respectively. Scott completed his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern. Following internship, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000.
Scott has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, Scott’s research has been supported by 7 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, FDA, and EPA. He currently holds a K24 career development award from NIDA. Scott has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. Scott is an elected member of both the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology and is a Fellow of the American Psychological Association Division 28 (Psychopharmacology and Substance Abuse). He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. Scott is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. Scott’s research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.